-
Recent Posts
- Moving Is a Monumental Task for Many Older Americans. These Organizers Can Help.
- Jynneos Vaccine Offers Protection Against Mpox, New Studies Confirm
- Corporate Giants Buy Up Primary Care Practices at Rapid Pace
- Too Many Older Men Are Still Screened for Prostate Cancer
- One Dose of HPV Vaccine Prevents Infection for at Least Three Years
Archives
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- December 2018
- November 2018
- October 2018
- July 2018
- February 2018
- August 2017
- July 2017
- March 2017
- February 2017
- July 2016
- June 2016
- June 2015
- May 2015
- January 2015
- October 2014
- February 2014
- December 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- October 2012
- May 2012
- March 2012
- February 2012
- November 2011
Categories
AddThis
Meta
Tweets and retweets
Tweets by toffanin
Monthly Archives: November 2021
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
BY STEPHANIE NOLEN | NYTimes Health | Disclosure from Blogger https://ift.tt/3IbU1me via SEO Services
Regeneron says its antibody treatment may not be as effective against Omicron, but testing is underway.
BY BENJAMIN MUELLER | NYTimes Health | Disclosure from Blogger https://ift.tt/2ZHwZlI via SEO Services
The C.D.C. strengthened its booster recommendations as worries mount over the Omicron variant.
BY APOORVA MANDAVILLI | NYTimes Health | Disclosure from Blogger https://ift.tt/3I4VgU4 via SEO Services
Omicron carries scary mutations. That doesn’t mean they work well together.
BY APOORVA MANDAVILLI | NYTimes Health | Disclosure from Blogger https://ift.tt/3E15geB via SEO Services
Antiviral Covid Pills Are Coming. Will There Be Enough Tests?
BY EMILY ANTHES | NYTimes Health | Disclosure from Blogger https://ift.tt/3d064o9 via SEO Services
Antiviral Covid Pills Are Coming. Will There Be Enough Tests?
BY EMILY ANTHES | NYTimes Health | Disclosure from Blogger https://ift.tt/3rjJfUJ via SEO Services
Does Omicron cause only mild illness? The jury is still out.
BY APOORVA MANDAVILLI | NYTimes Health | Disclosure from Blogger https://ift.tt/3HTIdVk via SEO Services
As Covid Infections Spread, Nursing Homes Lag Behind on the Rollout for Booster Shots
BY REED ABELSON | NYTimes Health | Disclosure from Blogger https://ift.tt/3cTN5LX via SEO Services
Renato Toffanin's Blog 